Conversely, increasingly prevalence of specific DPMs in the brain may serve as useful biomarkers of disease, such as elevated tissue levels of hyper-phosphorylated Tau, which has previously been used in the diagnosis of dementia [96]. The gene discussed is MAPT; the disease is dementia.